Medex Diagnósticos Company
The Chronic Non-communicable Diseases in Brazil were accountable for 72% of total deaths in 2017. Medex offers solutions on monitoring and diagnostics preventing and contributing to diminish and control these diseases in Brazil. As DCNTs foram responsáveis por 72% dos óbitos no país em 2017(Ministério da Saúde). A Medex oferece soluções em monitoramento e diagnóstico, contribuindo na prevenção e tratamento dessas doenças, por um Brasil mais saudável.
Headquarters:
Latin America
Funding Status:
Seed
Employee Number:
11-50
Last Funding Type:
Seed
Technology:
Other
Investor Type:
For Profit
Investors Number:
1
Founded Date:
2014-01-01
Industry:
P4 Medicine